Navigation Links
Drug shows promise for the first time against metastatic melanoma of the eye
Date:6/19/2014

NEW YORK, NY (June 19, 2014) For the first time, a therapy has been found that can delay progression of metastatic uveal melanoma, a rare and deadly form of melanoma of the eye.

Results from a multicenter clinical trial show that a new drug called selumetinib increases progression-free survival, the length of time during and after treatment that a patient with metastases lives with the disease without it progressing. The findings were published today in the online edition of JAMA, the Journal of the American Medical Association.

"Although the effects of the drug were modest, we now know that we can influence the course of the disease, and we expect to build on this success with other drugs, including some already in development," said senior author, Gary K. Schwartz, MD, professor of medicine and chief of hematology/oncology at NewYork-Presbyterian/Columbia University Medical Center and associate director of its Herbert Irving Comprehensive Cancer Center. (At the time of the trial, Dr. Schwartz was chief of the melanoma and sarcoma service at Memorial Sloan Kettering Cancer Center in New York.)

Uveal melanoma is a cancer of the iris, ciliary body, or choroidstructures in the eye collectively known as the uvea. Uveal melanoma (which is biologically distinct from skin melanoma) arises from the uvea's melanocytes, the pigment cells that give the eye its color. Once the disease has spreadmost metastases appear in the liverexisting treatments are largely ineffective. About 1,500 cases of uveal melanoma occur in the United States each year, usually among older adults. The median survival rate for patients with metastatic uveal melanoma is 12 months.

Several years ago, researchers found that 80 percent of patients with uveal melanoma had mutations to GNAQ or GNA11, genes that activate signals in the mitogen-activated protein kinase (MAPK) pathway. Dr. Schwartz and others subsequently demonstrated that inhibition of M
'/>"/>

Contact: Karin Eskenazi
Ket2116@columbia.edu
Columbia University Medical Center
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. BU-lead study shows surprising spread of spring leaf-out times
2. Study shows race a factor in mortality in heart attack patients on anti-clotting drug
3. Arctic warming linked to fewer European and US cold weather extremes, new study shows
4. New study shows that oatmeal can help you feel full longer
5. Saving trees in tropics could cut emissions by one-fifth, study shows
6. Doing more means changing less when it comes to gene response, new study shows
7. Research shows compassion and euthanasia dont always jibe
8. Study shows impact of tart cherries on inflammation and oxidative stress after cycling
9. Marijuana shows potential in treating autoimmune disease
10. Study shows tale of 2 prognoses in pediatric brain tumor, pilocytic astrocytoma
11. ALK, ROS1 and now NTRK1: Study shows prevalence of new genetic driver in lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug shows promise for the first time against metastatic melanoma of the eye
(Date:12/17/2014)... The Defense Logistics Agency is insourcing its efforts ... microcircuits from entering into its supply chain. ... initiative dubbed DNA marking. The capability will validate the ... the supply chain. The new quality control measures will ...
(Date:12/17/2014)... Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) has announced the ... report to their offering. ... in this market is the increasing demand for medical ... of patient data for quick and correct diagnosis during ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... 2015-2019"  report to their offering. One ... technology. With continuous advances in technology, it is important ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... physicians, researchers and academics from around the world ... for Digestive Disease Week (DDW), the premiere scientific ... and gastrointestinal surgery. Each day of ... on a broad variety of gastrointestinal health issues: ...
... it doesn,t look much different than its kin at the ... deceiving. This one, a Lovell variety, has a unique genetic ... DNA its genetic set of instructions for living ... beneficial traits to grow better trees and fruit. The ...
... have developed two advanced broadband acoustic systems that they ... from black-and-white television to high-definition color TV. For oceanographers, ... to count and classify fish and to pinpoint tiny ... Stanton and Andone Lavery in the Department of Applied ...
Cached Biology News:Latest research on GI health presented at DDW 2010 2Researchers sequence DNA of peach tree at Clemson University 2Researchers sequence DNA of peach tree at Clemson University 3Now in broadband: Acoustic imaging of the ocean 2Now in broadband: Acoustic imaging of the ocean 3Now in broadband: Acoustic imaging of the ocean 4Now in broadband: Acoustic imaging of the ocean 5
(Date:1/22/2015)... BOSTON , Jan. 22, 2015  Transwestern | RBJ today ... feet of office space for Shire a leading biopharmaceutical company, ... . Transwestern | RBJ,s Robert Richards , president, and ... the lease for the entire five-floor building at 95 Hayden ...
(Date:1/22/2015)... laboratory information management systems market is a rapidly growing ... due to factors such as rising pressure to comply ... and increasing government support for adoption of HCIT solutions ... the market focus on technological advancements to further the ...
(Date:1/22/2015)... zFlo Motion , a US leader in biomechanics ... from a new partner. STT-Systems has developed an ... years, with offerings in the optical-motion capture, 3D scanning, and ... measurement unit), iSen, is opening eyes around the world. With ...
(Date:1/22/2015)... 2015 Diagenode, Inc., a leading ... Bioruptor® and complete solutions for epigenetics research, recently ... alleviating the need for manual processing. The new ... ChIP of histones or transcription factors and a ...
Breaking Biology Technology:Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 43D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2
... Calif., Aug. 30 ThermoGenesis Corp. (Nasdaq: KOOLD ... process and store adult stem cells, said today it has ... HealthBanks, which operates cord blood banks in Taiwan, ... of 20 BioArchives and a storage capacity for cryopreserving and ...
... Dr. Kyong S. Choe, of Kwangju, South Korea, has been ... outstanding contributions and achievements in the field of healthcare. ... Dr. Choe is currently practicing with Feldman, Fitzgerald ... periodontics and prosthodontics targeting implants and full prosthetic reconstruction.  He ...
... <meta name="description" content="Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange. - ... Amex Beginning Monday, September 6, 2010 under the Ticker Symbol PLX -,- Company ... 10, 2010." /> Protalix BioTherapeutics to Dual List on Tel Aviv ... ...
Cached Biology Technology:ThermoGenesis Announces Sale of BioArchive Systems In Asia as Company Increases Presence In Key Market 2ThermoGenesis Announces Sale of BioArchive Systems In Asia as Company Increases Presence In Key Market 3Dr. Kyong S. Choe Recognized by Strathmore's Who's Who Worldwide Publication 2Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 2Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 3Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 4Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 5Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 6Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 7Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 8
... low background ,This solution greatly enhances antigen-antibody ... than obtained with conventional methods. ,Two kinds ... secondary antibodies, which can suppress the background ... Wide versatility ,It is applicable to various ...
Mouse Anti-Human Killer Cell Immunoglobulin-like Receptor, Two Domains, Long Cytoplasmic Tail, 2 (KIR2DL2 (KIR2DL3 Monoclonal Antibody Family: Immunoglobulin Sub-Family: not assigned-Immunogl...
pH-dependent fluorescence; Maximum intensity observed in basic solutions....
Mouse anti human pro-Relaxin-2...
Biology Products: